. AshcroftR: What is clinical effectiveness?Stud Hist Phil Biol & Biomed Sci, 33:219–233, 2002.
2.
. BeauchampTLChildressJF: Principles of biomedical ethics, 6th edn. New York: Oxford University Press; 2009.
3.
. CoulterAHamC: The global challenge of health care rationing. Buckingham; Philadelphia, PA: Open University Press; 2000.
4.
. CulyerAJ: Equity of what in healthcare? Why the traditional answers don't help policy—and what to do in the future. Healthcare Papers. 8 Spec No:12-26, 2007.
5.
. DanielsN: Justice, health, and healthcare. The American journal of bioethics : AJOB1(2): 2–16, 2001.
6.
. DanielsNSabinJE: Setting limits fairly can we learn to share medical resources? In. Oxford; New York: Oxford University Press; 2002: xi, 191 p.
. GuytonGP: Theoretical limitations of the AOFAS scoring systems: an analysis using Monte Carlo modeling. Foot Ankle Int. 22(10): 779–787, 2001.
9.
. HolmS: The second phase of priority setting. Goodbye to the simple solutions: the second phase of priority setting in health care. BMJ. 317(7164):1000–1002, 1998. http://dx.doi.org/10.1136/bmj.317.7164.1000
10.
. MayichJCoxJLButhKJLegareJF: Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock. Can J Cardio22(4): 331–335, 2006. http://dx.doi.org/10.1016/S0828-282X(06)70918-7
11.
. NorrisF: A Bleak Outlook for Long-Term Growth. In: New York Times. New York, NY, USA; 2012: B3.
12.
. PeacockSRutaDMittonCDonaldsonCBateAMurtaghM: Using economics to set pragmatic and ethical priorities. BMJ. 332(7539):482–485, 2006. http://dx.doi.org/10.1136/bmj.332.7539.482
13.
. PearR: Panel Says U.S. Should Weigh Cost in Deciding 'Essential Health Benefits'. In: New York Times. New York, NY, USA; 2011: A14.
14.
. PinskerEDanielsTR: AOFAS position statement regarding the future of the AOFAS Clinical Rating Systems. Foot Ankle Int. 32(9): 841–2, 2011. http://dx.doi.org/10.3113/FAI.2011.0841
15.
. RawlsJ: A theory of justice. Cambridge, Mass.: Belknap Press of Harvard University Press; 1971.
16.
. SiegelJEWeinsteinMCRussellLBGoldMR: Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 276(16): 1339–1341, 1996. http://dx.doi.org/10.1001/jama.276.16.1339
17.
. SooHooNFShulerMFlemingLL: Evaluation of the validity of the AOFAS Clinical Rating Systems by correlation to the SF-36. Foot Ankle Int. 24(1): 50–55, 2003.
18.
. WeinsteinMCSiegelJEGoldMRKamletMSRussellLB: Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 276(15): 1253–1258, 1996.